Identification of novel and potent triazoles targeting CYP51 for antifungal: Design, synthesis, and biological study
Authors:
- 5 October 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 280, 116942
Abstract
No abstract availableKeywords
Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China
This publication has 29 references indexed in Scilit:
- Strategies of targeting CYP51 for IFIs therapy: Emerging prospects, opportunities and challengesEuropean Journal of Medicinal Chemistry, 2023
- Oteseconazole: First ApprovalDrugs, 2022
- Design, synthesis and evaluation of novel 5-phenylthiophene derivatives as potent fungicidal of Candida albicans and antifungal reagents of fluconazole-resistant fungiEuropean Journal of Medicinal Chemistry, 2021
- Improving the metabolic stability of antifungal compounds based on a scaffold hopping strategy: Design, synthesis, and structure-activity relationship studies of dihydrooxazole derivativesEuropean Journal of Medicinal Chemistry, 2021
- Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infectionsEuropean Journal of Medicinal Chemistry, 2021
- Design, synthesis, and biological evaluation of novel miconazole analogues containing selenium as potent antifungal agentsEuropean Journal of Medicinal Chemistry, 2020
- Overview of Treatment Approaches for Fungal InfectionsClinics in Chest Medicine, 2017
- An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapyEuropean Journal of Medicinal Chemistry, 2017
- Structural Basis of Human CYP51 Inhibition by Antifungal AzolesJournal of Molecular Biology, 2010
- Current challenges in the management of invasive fungal infectionsJournal of Infection and Chemotherapy, 2008